Low-dose interleukin-2 in patients with mild to moderate Alzheimer’s disease: a randomized clinical trial by Alireza Faridar, Nazaret Gamez, Daling Li, Yanling Wang, Reena Boradia, Aaron D. Thome, Weihua Zhao, David R. Beers, Jason R. Thonhoff, Mohammad O. Nakawah, Gustavo C. Román, John J. Volpi, Jon B. Toledo, Michael George, Charles S. Davis, Belen Pascual, Michael Grundman, Joseph C. Masdeu, Stanley H. Appel

Get full text